Lumexa Imaging (NASDAQ:LMRI) Downgraded by Wall Street Zen to Hold

Wall Street Zen cut shares of Lumexa Imaging (NASDAQ:LMRI) from a buy rating to a hold rating in a report issued on Saturday morning,Wall Street Zen reports.

Several other equities analysts have also commented on the stock. Weiss Ratings upgraded shares of Lumexa Imaging from a “sell (e)” rating to a “sell (d)” rating in a report on Thursday, June 25th. Barclays lifted their target price on shares of Lumexa Imaging from $9.00 to $13.00 and gave the company an “overweight” rating in a report on Friday, August 28th. Finally, Deutsche Bank Aktiengesellschaft set a $16.00 price target on Lumexa Imaging in a research note on Thursday, August 13th. One analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and one has given a Sell rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $17.33.

Lumexa Imaging Stock Up 2.7%

Shares of NASDAQ:LMRI opened at $11.49 on Friday. The business has a 50-day moving average price of $11.53 and a 200 day moving average price of $10.70. The company has a current ratio of 1.44, a quick ratio of 1.44 and a debt-to-equity ratio of 1.40. The company has a market capitalization of $1.10 billion and a price-to-earnings ratio of -23.45. Lumexa Imaging has a 12-month low of $6.45 and a 12-month high of $19.45.

Lumexa Imaging (NASDAQ:LMRI) last posted its earnings results on Wednesday, August 12th. The company reported $0.20 EPS for the quarter, beating analysts’ consensus estimates of $0.03 by $0.17. The company had revenue of $264.16 million during the quarter. Lumexa Imaging has set its FY 2026 guidance at 0.710-0.770 EPS. Sell-side analysts expect that Lumexa Imaging will post 0.25 EPS for the current year.

Institutional Investors Weigh In On Lumexa Imaging

Several large investors have recently added to or reduced their stakes in LMRI. Renaissance Technologies LLC purchased a new stake in Lumexa Imaging during the 1st quarter worth about $778,000. Bank of America Corp DE boosted its stake in shares of Lumexa Imaging by 1,855,116.7% in the 1st quarter. Bank of America Corp DE now owns 111,313 shares of the company’s stock valued at $957,000 after buying an additional 111,307 shares during the period. Brigade Capital Management LP purchased a new position in shares of Lumexa Imaging in the 2nd quarter valued at about $7,511,000. Janus Henderson Group PLC grew its position in shares of Lumexa Imaging by 5.4% during the first quarter. Janus Henderson Group PLC now owns 2,100,356 shares of the company’s stock worth $18,063,000 after buying an additional 107,903 shares in the last quarter. Finally, BlackRock Inc. purchased a new stake in shares of Lumexa Imaging during the second quarter worth approximately $15,771,000.

Lumexa Imaging Company Profile

Lumexa Imaging, Inc (NASDAQ: LMRI) is an outpatient diagnostic imaging company that provides medical imaging services to patients and referring healthcare providers in the United States. Its services are designed to support the diagnosis, monitoring and management of a wide range of medical conditions.

The company’s imaging capabilities include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET/CT), ultrasound, mammography and X-ray services. Lumexa also provides related radiology and imaging-support services through its outpatient centers and other care-delivery arrangements.

Lumexa Imaging was formerly known as Akumin Inc and adopted the Lumexa Imaging name as part of its corporate rebranding.